ICAM1 and breast cancer: Schröder et al. documented the association between ICAM-1 mRNA in breast cancer, high levels of urokine plasminogen (uPA) and uPA-1 inhibitor (PAI 1), and Ki67 and VEGF mRNA overexpression [134].